Compound 2043
Identifiers
- Canonical SMILES:
COC(=O)N1[C@@H](C)CN(C(=O)c2ccco2)c2cc(ccc12)-c1ccc(cc1)S(C)(=O)=O
- IUPAC name:
methyl (2S)-4-(furan-2-carbonyl)-6-(4-methanesulfonylphenyl)-2-methyl-1,2,3,4-tetrahydroquinoxaline-1-carboxylate
- InChi:
InChI=1S/C23H22N2O6S/c1-15-14-24(22(26)21-5-4-12-31-21)20-13-17(8-11-19(20)25(15)23(27)30-2)16-6-9-18(10-7-16)32(3,28)29/h4-13,15H,14H2,1-3H3/t15-/m0/s1
- InChiKey:
FNGHABKDXSWAPR-HNNXBMFYSA-N
External links
![]() 118317783 |
![]() CHEMBL4209209 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 6.49 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 454.12 g/mol | |||
HBA | 8 | |||
HBD | 0 | |||
HBA + HBD | 8 | |||
AlogP | 2.44 | |||
TPSA | 97.13 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 1 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acsmedchemlett.7b00191 | compound 14 | BRD4 Q9ESU6 |
H33 P84243 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 6.19 | |
10.1021/acsmedchemlett.7b00191 | compound 14 | BRD4 Q9ESU6 |
H33 P84243 |
Cellular assay | cellular viability MV4-11 | MV4-11 | pIC50 (half maximal inhibitory concentration, -log10) | 6.49 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4900 | 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE | DB07167 | |
0.4822 | 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide | DB08021 | |
0.4810 | N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide | DB07020 | |
0.4627 | Furosemide | DB00695 | |
0.4350 | Ombitasvir | DB09296 | |
0.4268 | N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide | DB03642 | |
0.4250 | Relacatib | DB06367 | |
0.4167 | Opaviraline | DB07884 | |
0.4150 | Delparantag | DB12955 | |
0.4061 | 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE | DB07403 | |
0.4061 | Bentiromide | DB00522 | |
0.4059 | Revefenacin | DB11855 | |
0.4038 | Vismodegib | DB08828 | |
0.4037 | AZD-7295 | DB12724 | |
0.4029 | Vesnarinone | DB12082 |